What are Preferred Products in Chronic Pain Treatment Market?

1. Chronic Pain Treatment Drug and Device Sales To Boom in Future 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The World Health Organization (WHO) states that 2.26 million, 2.21 million, 1.93 million, 1.41 million, 1.20 million, and 1.09 million people were diagnosed with breast cancer, lung cancer, colon and rectum cancer, prostate cancer, skin (non-melanoma), and stomach cancer, respectively, in 2020. Moreover, Alzheimer's Disease International states that more than 55 million people were living with dementia in 2020 and the number will reach around 78 million by 2030 and 139 million by 2050. As such chronic and neurological diseases cause severe pain in affected patients, the surging cases of these illnesses will help the chronic pain treatment market advance at a CAGR of 7.2% during the forecast period (2020–2030). According to P&S Intelligence, the market was valued at $80,766.6 million in 2020, and it will generate $162,175.2 million revenue by 2030. Additionally, the rising government support being provided for chronic pain treatment and the expanding population base of old people will also drive the demand for chronic pain treatment drugs and devices. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/chronic-pain- treatment-market/report-sample Chronic pain treatment drugs, such as antidepressants, anticonvulsants, opioids, and non-steroidal anti-inflammatory drugs (NSAIDs), and devices, such as neurostimulation devices, ablation devices, and analgesic infusion pumps, are used to indicate and treat arthritis pain, cancer pain, chronic back pain, fibromyalgia, migraine, and neuropathic pain. In the coming years, a huge quantity of such drugs and devices will be used to treat cancer pain because of the rising cases of cancer. The International Agency for Research on Cancer (IARC) states that 19.3 million new cancer cases and 10.0 million cancer deaths were recorded in 2020. Currently, the chronic pain treatment market is highly competitive, with the presence of numerous key players, who are actively engaged in collaborations, partnerships, and product launches. For example, in July 2021, Nevro Corp., a medical device company, received FDA approval for Senza System. This product is used to treat chronic pain caused due to painful diabetic neuropathy (PDN). Other players opting for such strategic measures are Eli Lilly and Company, Sanofi S.A., Boston Scientific Corporation, Bristol-Myers Squibb Company, Medtronic plc, and Becton, Dickinson and Company. Make an Enquiry before Purchase: https://www.psmarketresearch.com/send- enquiry?enquiry-url=chronic-pain-treatment-market Globally, the North American region was the dominant user of chronic pain treatment drugs and devices in the last few years due to the widescale availability of advanced drugs and devices, the existence of developed healthcare infrastructure, and hefty healthcare expenditure. The Canadian Institute for Health Information (CIHI) states that $308 billion was spent in Canada in 2021. Likewise, the Centers for Disease Control and Prevention (CDC) estimates that the national health expenditure of the U.S. was $3.6 trillion in 2018. Whereas, the Asia-Pacific (APAC) chronic pain treatment market is expected to exhibit 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. the fastest growth throughout the forecast period, primarily on account of the rising per capita income, improving healthcare infrastructure, growing cases of chronic pain, and booming elderly population in the region. The United Nations Population Fund (UNFPA) forecasts that the population of individuals aged over 60 years in APAC will reach around 1.3 billion by 2050. Furthermore, the Reserve Bank of India (RBI) states that the per capita gross national income of India was INR 141,265 crore in the financial year (FY) 2018–2019. Thus, the growing burden of chronic health conditions and booming elderly population will create a huge requirement for chronic pain treatment products globally. The research offers market size of the global chronic pain treatment market for the period 2015–2030. Market Segmentation by Product  Drugs oOpioids oNon-steroidal anti-inflammatory drugs (NSAIDs) oAnticonvulsants oAntidepressants oOthers  Devices oNeurostimulation devices Spinal cord stimulation (SCS) devices Transcutaneous electrical nerve stimulation (TENS) devices Others    oAnalgesic infusion pumps oAblation devices Radiofrequency ablation devices Cryoablation devices   oOthers Market Segmentation by Indication  Neuropathic Pain Arthritis Pain Chronic Back Pain Cancer Pain Migraine Fibromyalgia Others       3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. Market Segmentation by Application  Musculoskeletal Neuropathy Oncology Others Market Segmentation by Distribution Channel     Direct Indirect Market Segmentation by End User   Hospitals  Clinics Nursing Homes Research Centers & Universities Others Market Segmentation by Region     North America Chronic Pain Treatment Market oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – U.S. and Canada U.S. chronic pain treatment market  By product By indication By application By distribution channel By end user Canada chronic pain treatment market By product By indication By application By distribution channel           4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. By end user Europe Chronic Pain Treatment Market   oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Germany, France, U.K., Italy, Spain, Netherlands, Russia, Sweden, Switzerland, and Rest of Europe Germany chronic pain treatment market By product By indication    By application By distribution channel By end user France chronic pain treatment market By product By indication By application By distribution channel By end user U.K. chronic pain treatment market By product By indication By application By distribution channel By end user                Italy chronic pain treatment market By product By indication By application By distribution channel By end user Spain chronic pain treatment market By product By indication          5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

6. By application By distribution channel   By end user Netherlands chronic pain treatment market By product By indication By application By distribution channel By end user Russia chronic pain treatment market By product By indication           By application By distribution channel By end user Sweden chronic pain treatment market By product By indication By application By distribution channel By end user Switzerland chronic pain treatment market By product By indication By application By distribution channel By end user                 Asia-Pacific (APAC) Chronic Pain Treatment Market oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Japan, China, India, Australia, South Korea, and Rest of APAC Japan chronic pain treatment market By product   6 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

7. By indication By application   By distribution channel By end user China chronic pain treatment market By product By indication By application By distribution channel By end user India chronic pain treatment market By product           By indication By application By distribution channel By end user Australia chronic pain treatment market By product By indication By application By distribution channel By end user South Korea chronic pain treatment market By product By indication By application By distribution channel                By end user Latin America (LATAM) Chronic Pain Treatment Market   oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Brazil, Mexico, and Rest of LATAM Brazil chronic pain treatment market  7 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

8. By product By indication   By application By distribution channel By end user Mexico chronic pain treatment market By product By indication By application By distribution channel By end user Middle East and Africa (MEA) Chronic Pain Treatment Market           oBy product oBy indication oBy application oBy distribution channel oBy end user oBy country – Saudi Arabia, South Africa, and Rest of MEA Saudi Arabia chronic pain treatment market By product By indication By application By distribution channel By end user South Africa chronic pain treatment market By product By indication          By application By distribution channel By end user    8 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

9. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 9 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved